TN2011000038A1 - Nitrogenated derivatives of pancratistatin - Google Patents

Nitrogenated derivatives of pancratistatin

Info

Publication number
TN2011000038A1
TN2011000038A1 TN2011000038A TN2011000038A TN2011000038A1 TN 2011000038 A1 TN2011000038 A1 TN 2011000038A1 TN 2011000038 A TN2011000038 A TN 2011000038A TN 2011000038 A TN2011000038 A TN 2011000038A TN 2011000038 A1 TN2011000038 A1 TN 2011000038A1
Authority
TN
Tunisia
Prior art keywords
pancratistatin
nitrogenated
derivatives
nitrogenated derivatives
well
Prior art date
Application number
TN2011000038A
Other languages
English (en)
Inventor
Frederic Marion
Jean-Philippe Annereau
Jacques Fahy
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/059715 external-priority patent/WO2010012714A1/fr
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of TN2011000038A1 publication Critical patent/TN2011000038A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TN2011000038A 2009-07-28 2011-01-26 Nitrogenated derivatives of pancratistatin TN2011000038A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/059715 WO2010012714A1 (fr) 2008-07-28 2009-07-28 Dérivés azotés de pancratistatine

Publications (1)

Publication Number Publication Date
TN2011000038A1 true TN2011000038A1 (en) 2012-09-05

Family

ID=55024352

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000038A TN2011000038A1 (en) 2009-07-28 2011-01-26 Nitrogenated derivatives of pancratistatin

Country Status (1)

Country Link
TN (1) TN2011000038A1 (fr)

Similar Documents

Publication Publication Date Title
SA515360469B1 (ar) مركبات حلقية غير متجانسة لتثبيط إنزيم جلوتاميناز والطرق الخاصة باستخدامها
TN2012000622A1 (en) Combinations of kinase inhibitors for the treatment of cancer
MX2013011332A (es) Combinaciones de compuestos inhibidores de akt y vemurafenib y metodos de uso de los mismos.
UA98141C2 (ru) Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа
NZ603155A (en) Phospholipid drug analogs
EA201100971A1 (ru) Производные пиримидининдола для лечения злокачественного новообразования
MX2009009786A (es) Inhibidores de la via de hedgehog.
PH12014501542A1 (en) Substituted pyrrolidine -2- carboxamides
HK1139863A1 (en) Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
MX2015017201A (es) Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga.
JO3115B1 (ar) مركبات بيريدازينون واستخدامها كمثبطات daao
MX2011011083A (es) Compuestos heterociclicos como inhibidores de mek.
CR20200286A (es) DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294)
MX2013012588A (es) Inhibidores de cinasa.
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
MX2014003376A (es) Derivados de acido benzoico como inhibidores eif4e.
GB201209587D0 (en) Therapeutic compounds
MX2013008340A (es) Novedosas 4-amino-n-hidroxi-benzamidas para el tratamiento de cancer.
PH12015500111A1 (en) Difluorolactam compositions for ep4-mediated osteo related diseases and conditions
WO2010121675A3 (fr) Thiazolyl-benzimidazoles
JO3145B1 (ar) مركبات مفيدة لتثبيط chk1
MA32588B1 (fr) Derives azotes de la pancratistatine
IN2012DN02816A (fr)
PH12015500399A1 (en) Azaindolines
TN2012000242A1 (en) Heterocyclic sulfonamide derivatives